The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The CombiRx trial of combined therapy with interferon and glatiramer acetate in relapsing remitting MS: Design and baseline characteristics

Published:2012-04 Issue:2 Volume:1 Page:81-86
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Lindsey J.W.,Scott T.F.,Lynch S.G.,Cofield S.S.,Nelson F.,Conwit R.,Gustafson T.,Cutter G.R.,Wolinsky J.S.,Lublin F.D.

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference25 articles.

1. Combination therapy with glatiramer acetate (copolymer-1) and a type I interferon (IFN-alpha) does not improve experimental autoimmune encephalomyelitis;Brod;Annals of Neurology,2000

2. Avonex combination trial in relapsing–remitting MS: rationale, design and baseline data;Cohen;Multiple Sclerosis,2008

3. Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial;Cohen;Archives of Neurology,2001

4. Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial;Comi;Lancet,2009

5. Multiple sclerosis;Compston;Lancet,2008

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis;Annals of Clinical and Translational Neurology;2024-05-07

2. Adverse effects of immunotherapies for multiple sclerosis: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-11-30

3. Polygenicity of Comorbid Depression in Multiple Sclerosis;Neurology;2023-08

4. Serum neurofilament light-chain levels and long-term treatment outcomes in relapsing-remitting multiple sclerosis patients: A post hoc analysis of the randomized CombiRx trial;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2023-04

5. Association of Vitamin D Polygenic Risk Scores and Disease Outcome in People With Multiple Sclerosis;Neurology - Neuroimmunology Neuroinflammation;2022-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3